These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 24021609

  • 1. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
    Garbacz G, Cadé D, Benameur H, Weitschies W.
    Eur J Pharm Sci; 2014 Jun 16; 57():264-72. PubMed ID: 24021609
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Jun 16; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 6. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K.
    Int J Pharm; 2010 Feb 15; 386(1-2):30-41. PubMed ID: 19900518
    [Abstract] [Full Text] [Related]

  • 7. Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: case example diclofenac sodium.
    Kambayashi A, Blume H, Dressman JB.
    Eur J Pharm Biopharm; 2014 Jul 15; 87(2):236-43. PubMed ID: 24462791
    [Abstract] [Full Text] [Related]

  • 8. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA, Danopoulos P, Demirdjian L, Nogueira RJ, Dubois F.
    Int J Pharm Compd; 2013 Jul 15; 17(5):424-31. PubMed ID: 24459788
    [Abstract] [Full Text] [Related]

  • 9. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003 Jul 15; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 10. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity.
    Ciper M, Bodmeier R.
    Eur J Pharm Biopharm; 2006 Feb 15; 62(2):178-84. PubMed ID: 16260126
    [Abstract] [Full Text] [Related]

  • 11. The in vitro dissolution of theophylline from different types of hard shell capsules.
    Podczeck F, Jones BE.
    Drug Dev Ind Pharm; 2002 Oct 15; 28(9):1163-9. PubMed ID: 12455475
    [Abstract] [Full Text] [Related]

  • 12. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET, Cadé D, Benameur H.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):747-56. PubMed ID: 18096270
    [Abstract] [Full Text] [Related]

  • 13. Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model.
    Vardakou M, Mercuri A, Naylor TA, Rizzo D, Butler JM, Connolly PC, Wickham MS, Faulks RM.
    Int J Pharm; 2011 Oct 31; 419(1-2):192-9. PubMed ID: 21843611
    [Abstract] [Full Text] [Related]

  • 14. Compounding of slow-release niacinamide capsules: feasibility and characterization.
    Radojkovic B, Milić J, Calija B.
    Int J Pharm Compd; 2012 Oct 31; 16(5):434-7. PubMed ID: 23072204
    [Abstract] [Full Text] [Related]

  • 15. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K, Sistla R, Shastri NR.
    Drug Deliv; 2015 May 31; 22(3):418-26. PubMed ID: 24471823
    [Abstract] [Full Text] [Related]

  • 16. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S, Jantratid E, Dressman JB.
    J Pharm Pharmacol; 2009 Mar 31; 61(3):331-7. PubMed ID: 19222905
    [Abstract] [Full Text] [Related]

  • 17. Floating gastroretentive drug delivery systems: Comparison of experimental and simulated dissolution profiles and floatation behavior.
    Eberle VA, Schoelkopf J, Gane PA, Alles R, Huwyler J, Puchkov M.
    Eur J Pharm Sci; 2014 Jul 16; 58():34-43. PubMed ID: 24704154
    [Abstract] [Full Text] [Related]

  • 18. In vitro simulation of realistic gastric pressure profiles.
    Schneider F, Beeck R, Hoppe M, Koziolek M, Weitschies W.
    Eur J Pharm Sci; 2017 Sep 30; 107():71-77. PubMed ID: 28673756
    [Abstract] [Full Text] [Related]

  • 19. Evaluating the sensitivity, reproducibility and flexibility of a method to test hard shell capsules intended for use in dry powder inhalers.
    Chong RH, Jones BE, Díez F, Birchall JC, Coulman SA.
    Int J Pharm; 2016 Mar 16; 500(1-2):316-25. PubMed ID: 26806464
    [Abstract] [Full Text] [Related]

  • 20. An integrated system for dissolution studies and magnetic resonance imaging of controlled release, polymer-based dosage forms-a tool for quantitative assessment of hydrogel formation processes.
    Kulinowski P, Dorozyński P, Jachowicz R, Weglarz WP.
    J Pharm Biomed Anal; 2008 Nov 04; 48(3):685-93. PubMed ID: 18715732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.